Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

This study is an offshoot of a broader 2022 clinical trial published in the New England Journal of Medicine, which found weekly doses of tirzepatide led to weight loss in up to 22.5% of participants.

Tirzepatide may be more effective than semaglutide in helping people who have obesity or overweight lose weight, results from a recent study suggest. ... results from a recent study suggest.

The study worked with 539,109 men who were diagnosed with insomnia, 356,575 of which were treated medically. “Men diagnosed with insomnia only were found to have a higher risk of developing ED ...

BOSTON - A new study in the journal Neurology finds that popular drugs used to treat erectile dysfunction, like Viagra, could help reduce the risk of Alzheimer's disease. Researchers in the U.K ...

Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for, respectively, diabetes and weight loss, reduced the risk of heart failure outcomes by 38% compared to placebo ...

A recent study conducted on medical students by Peruvian researchers found that there may be a link between a chronic gastrointestinal disorder and erectile dysfunction (ED).. The study, published ...

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.